CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis

PLoS Pathogens

Volumn 12, Issue 4, 2016, Pages

  Manivannan, Kiruthika ^a   Rowan, Aileen G ^a   Tanaka, Yuetsu ^b   Taylor, Graham P ^a   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; HEMOGLOBIN ZETA CHAIN; TAX PROTEIN; CADM1 PROTEIN, HUMAN; IMMUNOGLOBULIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; DOWN REGULATION; ELECTROPORATION; FLOW CYTOMETRY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLYMYOSITIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS LOAD; CYTOTOXICITY; HTLV-1 INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOLOGY; METABOLISM;

CELL ADHESION MOLECULES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOGLOBULINS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84964828879     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005560     Document Type: Article

References (49)

1. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A. 1999Mar30;96(7):3848–53. 10097126
2. Nejmeddine M, Bangham CRM, The HTLV-1 Virological Synapse. Viruses. 2010Jul;2(7):1427–47. doi: 10.3390/v207142721994688
3. Wodarz D, Nowak MA, Bangham CR, The dynamics of HTLV-I and the CTL response. Immunol Today. 1999May;20(5):220–7. 10322301
4. Okochi K, Sato H, Hinuma Y, A retrospective study on transmission of adult T cell leukaemia by blood transfusion: seroconversion in recipients. Vox Sanguis. 1984;46:245–53.
5. Meekings KN, Leipzig J, Bushman FD, Taylor GP, Bangham CRM, HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog. 2008Mar;4(3):e1000027. doi: 10.1371/journal.ppat.100002718369476
6. Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CRM, Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog. 2013Mar;9(3):e1003271. doi: 10.1371/journal.ppat.100327123555266
7. Matsuoka M, Jeang K, . Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene. Nature Publishing Group; 2011Mar24;30(12):1379–89. doi: 10.1038/onc.2010.53721119600
8. Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, et al. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol. 2001;7(3):228–34. 11517397
9. Bangham CRM, The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol. 2003Dec1;84(Pt 12):3177–89. 14645900
10. Vine AM, Heaps AG, Kaftantzi L, Mosley A, Asquith B, Witkover A, et al. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol. 2004Oct;173(8):5121–9. 15470056
11. Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S, et al. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol. 1995;69(4):2649–53. 7533860
12. Asquith B, Mosley AJ, Barfield A, Marshall SEF, Heaps A, Goon P, et al. A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol. 2005May;86(Pt 5):1515–23. 15831965
13. Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996Oct15;88(8):3065–73. 8874205
14. Okazaki S, Moriuchi R, Yosizuka N, Sugahara K, Maeda T, Jinnai I, et al. HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia. Virus Genes. 2001Jan;23(2):123–35. 11724264
15. Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J-I, Nosaka K, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004Apr;109(4):559–67. 14991578
16. Yoshida M, Satou Y, Yasunaga J-I, Fujisawa J-I, Matsuoka M, Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. J Virol. 2008Oct;82(19):9359–68. doi: 10.1128/JVI.00242-0818653454
17. Rowan AG, Suemori K, Fujiwara H, Yasukawa M, Tanaka Y, Taylor GP, et al. Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression. Retrovirology. 2014;11(1):116.
18. Macnamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K, et al. HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog. 2010Jan;6(9):e1001117. doi: 10.1371/journal.ppat.100111720886101
19. Sugata K, Yasunaga J-I, Mitobe Y, Miura M, Miyazato P, Kohara M, et al. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor. Blood. 2015Aug27;126(9):1095–105. doi: 10.1182/blood-2015-04-64111826063164
20. Yamano Y, Cohen CJ, Takenouchi N, Yao K, Tomaru U, Li H-C, et al. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in pati. J Exp Med. 2004May17;199(10):1367–77. 15136590
21. Yoshie O, Fujisawa R, Nakayama T, Harasawa H, Tago H, Izawa D, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood. 2002Mar;99(5):1505–11. 11861261
22. Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res. 2003Sep1;9(10 Pt 1):3625–34. 14506150
23. Fukudome K, Furuse M, Fukuhara N, Orita S, Imai T, Takagi S, et al. Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines. Int J cancer. 1992;52:418–27. 1356935
24. Yamamoto A, Hara H, Kobayashi T, Induction of the expression of gag protein in HTLV-I infected lymphocytes by anti-ICAM 1 antibody in vitro. J Neurol Sci. 1997Oct;151(2):121–6. 9349665
25. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M, Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 1986;5(11):2883–8. 3024966
26. Hieshima K, Nagakubo D, Nakayama T, Shirakawa A- K, Jin Z, Yoshie O, Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol. 2008;180(2):931–9. 18178833
27. Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D, et al. Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One. 2009Jan;4(8):e6517. doi: 10.1371/journal.pone.000651719654865
28. Tanaka Y, Fukudome K, Hayashi M, Takagi S, Yoshie O, Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines. Int J Cancer. 1995Feb;60(4):554–61. 7530239
29. Nejmeddine M, Barnard AL, Tanaka Y, Taylor GP, Bangham CRM, Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J Biol Chem. 2005Aug;280(33):29653–60. 15975923
30. Nejmeddine M, Negi VS, Mukherjee S, Tanaka Y, Orth K, Taylor GP, et al. HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood. 2009Jul30;114(5):1016–25. doi: 10.1182/blood-2008-03-13677019494354
31. Sasaki Hidenori, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T, et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood. 2005;105(3):1204–14. 15471956
32. Nakahata S, Saito Y, Marutsuka K, Hidaka T, Maeda K, Hatakeyama K, et al. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma. Leukemia. 2012Jun;26(6):1238–46. doi: 10.1038/leu.2011.37922289924
33. Nakahata S, Morishita K, CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma. J Clin Exp Hematop. 2012Jan;52(1):17–22. 22706526
34. Gomyo H, Arai Y, Tanigami A, Murakami Y, Hattori M, Hosoda F, et al. A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2. Genomics. 1999Dec;62(2):139–46. 10610705
35. Shingai T, Ikeda W, Kakunaga S, Morimoto K, Takekuni K, Itoh S, et al. Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells. J Biol Chem. 2003Sep;278(37):35421–7. 12826663
36. Masuda M, Yageta M, Fukuhara H, Kuramochi M, Maruyama T, Nomoto A, et al. The tumor suppressor protein TSLC1 is involved in cell-cell adhesion. J Biol Chem. 2002Aug;277(34):31014–9. 12050160
37. Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, et al. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res. 2002Sep;62(18):5129–33. 12234973
38. Boles KS, Barchet W, Diacovo T, Cella M, Colonna M, The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood. 2005Aug1;106(3):779–86. 15811952
39. Arase N, Takeuchi A, Unno M, Hirano S, Yokosuka T, Arase H, et al. Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+T cells. Int Immunol. 2005Sep;17(9):1227–37. 16091383
40. Dewan MZ, Takamatsu N, Hidaka T, Hatakeyama K, Nakahata S, Fujisawa J, et al. Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vivo. J Virol. 2008Dec;82(23):11958–63. doi: 10.1128/JVI.01149-0818922876
41. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CRM, HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood. 2012Oct25;120(17):3488–90. doi: 10.1182/blood-2012-07-44559322955925
42. Satou Y, Yasunaga J, Yoshida M, Matsuoka M, HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A. 2006Jan17;103(3):720–5. 16407133
43. Kattan T, MacNamara A, Rowan AG, Nose H, Mosley AJ, Tanaka Y, et al. The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol. 2009May1;182(9):5723–9. doi: 10.4049/jimmunol.090006919380819
44. Laydon DJ, Melamed A, Sim A, Gillet NA, Sim K, Darko S, et al. Quantification of HTLV-1 clonality and TCR diversity. PLoS Comput Biol. 2014Jun;10(6):e1003646. doi: 10.1371/journal.pcbi.100364624945836
45. Kobayashi S, Nakano K, Watanabe E, Ishigaki T, Ohno N, Yuji K, et al. CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma. Clin Cancer Res. 2014Jun1;20(11):2851–61. doi: 10.1158/1078-0432.CCR-13-316924727323
46. Kobayashi S, Watanabe E, Ishigaki T, Ohno N, Yuji K, Nakano K, et al. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry. Cancer Sci. 2015May;106(5):598–603. doi: 10.1111/cas.1263925703103
47. Pujari R, Hunte R, Thomas R, van der Weyden L, Rauch D, Ratner L, et al. Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling. PLoS Pathog. Public Library of Science; 2015Mar;11(3):e1004721. doi: 10.1371/journal.ppat.100472125774694
48. Peloponese J-M, Haller K, Miyazato A, Jeang K-T, Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc Natl Acad Sci U S A. 2005;102(52):18974–9. 16365316
49. Clerc I, Hivin P, Rubbo PA, Lemasson I, Barbeau B, Mesnard JM, Propensity for HBZ-SP1 isoform of HTLV-I to inhibit c-Jun activity correlates with sequestration of c-Jun into nuclear bodies rather than inhibition of its DNA-binding activity. Virology. Elsevier Inc.; 2009;391(2):195–202. doi: 10.1016/j.virol.2009.06.02719595408